glucose, (beta-d)-isomer has been researched along with Diffuse Parenchymal Lung Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Li, Y; Long, X; Luo, C; Tang, W; Xie, L; Zhang, Q | 1 |
Akashi, K; Morinobu, A; Okano, T; Saegusa, J; Sendo, S; Takahashi, S | 1 |
Ishikawa, Y; Mimori, T; Murakami, K; Shimizu, M; Shiomi, A; Usui, T | 1 |
3 other study(ies) available for glucose, (beta-d)-isomer and Diffuse Parenchymal Lung Disease
Article | Year |
---|---|
Stattic alleviates pulmonary fibrosis in a mouse model of rheumatoid arthritis-relevant interstitial lung disease.
Topics: Animals; Arthritis, Rheumatoid; Collagen; Disease Models, Animal; Female; Humans; Lung Diseases, Interstitial; Mice; Pulmonary Fibrosis; Transforming Growth Factor beta1; Zymosan | 2023 |
CD11b+Gr-1
Topics: Adoptive Transfer; Animals; CD11b Antigen; Cell Differentiation; Cell Proliferation; Coculture Techniques; Dendritic Cells; Disease Models, Animal; Flow Cytometry; Fluoresceins; Granulocyte-Macrophage Colony-Stimulating Factor; Interleukin-4; Lung; Lung Diseases, Interstitial; Mice; Myeloid-Derived Suppressor Cells; Receptors, Chemokine; Succinimides; T-Lymphocytes; Th17 Cells; Zymosan | 2017 |
GM-CSF but not IL-17 is critical for the development of severe interstitial lung disease in SKG mice.
Topics: Animals; Antibodies, Neutralizing; Arthritis; CD4-Positive T-Lymphocytes; Cells, Cultured; Connective Tissue Diseases; Disease Models, Animal; Female; Flow Cytometry; Granulocyte-Macrophage Colony-Stimulating Factor; Interleukin-17; Interleukin-1beta; Interleukin-6; Lung; Lung Diseases, Interstitial; Macrophages; Mice; Mice, Inbred BALB C; Neutrophils; Severity of Illness Index; Th17 Cells; Time Factors; Zymosan | 2014 |